United Therapeutics Aktie
WKN: 923818 / ISIN: US91307C1027
|
29.10.2025 11:40:00
|
United Therapeutics Corp Announces Rise In Q3 Bottom Line
(RTTNews) - United Therapeutics Corp (UTHR) reported a profit for its third quarter that Increased, from last year
The company's bottom line totaled $338.7 million, or $7.16 per share. This compares with $309.1 million, or $6.39 per share, last year.
The company's revenue for the period rose 6.8% to $799.5 million from $748.9 million last year.
United Therapeutics Corp earnings at a glance (GAAP) :
-Earnings: $338.7 Mln. vs. $309.1 Mln. last year. -EPS: $7.16 vs. $6.39 last year. -Revenue: $799.5 Mln vs. $748.9 Mln last year.
Der finanzen.at Ratgeber für Aktien!
Wenn Sie mehr über das Thema Aktien erfahren wollen, finden Sie in unserem Ratgeber viele interessante Artikel dazu!
Jetzt informieren!
Nachrichten zu United Therapeutics Corp.mehr Nachrichten
Analysen zu United Therapeutics Corp.mehr Analysen
Aktien in diesem Artikel
| United Therapeutics Corp. | 381,90 | -3,29% |
|